Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study.

ABSTRACT:

Objectives

To evaluate the short-term (12 weeks) safety and utilisation of rivaroxaban prescribed to new-user adult patients for the treatment of deep vein thrombosis and pulmonary embolism and for the prevention of recurrent deep vein thrombosis and pulmonary embolism in a secondary care setting in England and Wales.

Design

An observational cohort study using the technique of Specialist Cohort Event Monitoring.

Setting

The Rivaroxaban Observational Safety Evaluation study was conducted across 87 participating National Health Service secondary care trusts in England and Wales.

Participants

1532 patients treated with rivaroxaban for the prevention and treatment of deep vein thrombosis/pulmonary embolism from September 2013 to January 2016.

Interventions

N

SUBMITTER: Evans A 

PROVIDER: S-EPMC7640735 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature